Navigation Links
Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010
Date:2/10/2011

gyProprietary OncologyTREANDA393,473-393,473222,112-222,11277-77Other Proprietary Oncology20,86676,25697,12218,28175,36093,6411414Generic Oncology-22,99822,998-20,94020,940-1010Oncology414,33999,254513,593240,39396,300336,69372353OtherOther Proprietary15,1125,80920,92117,545-17,545(14)10019Other Generic13,220292,562305,78215,436108,922124,358(14)169146Other28,332298,371326,70332,981108,922141,903(14)174130$ 2,102,175$ 658,777$ 2,760,952$ 1,768,383$ 383,165$ 2,151,54819%72%28% Europe- Primarily Europe, Middle East and Africa Proprietary products are products which are sold under patent coverage.   Generic products are products sold without patent coverage in the primary sales territory. Patent coverage may exist in other territories.   CEPHALON, INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS(In thousands, except share data)(Unaudited) December 31, 20102009CURRENT ASSETS:   Cash and cash equivalents

$ 1,160,239$ 1,647,635   Receivables, net

431,333376,076   Inventory, net

291,360240,576   Deferred tax assets, net

213,798243,246   Other current assets

54,84558,423Total current assets

2,151,5752,565,956   INVESTMENTS ($155,808 at fair value in 2010)

168,49412,427   PROPERTY AND EQUIPMENT, net

502,856451,879   GOODWILL

822,071590,284   INTANGIBLE ASSETS, net

1,212,387981,857   DEBT ISSUANCE COSTS

14,19618,862   OTHER ASSETS

20,25436,830$ 4,891,833$ 4,658,095CURRENT LIABILITIES:   Current portion of long-term debt, net

$
51,997$
818,925   Accounts payable

104,47788,829   Accrued expenses

460,141430,209Total current liabilities

1,216,6151,337,963   LONG-TERM DEBT

391,416363,696   DEFERRED TAX LIABILITIES, net

172,589159,328   OTHER LIABILITIES

273,438111,728Total liabilities

2,054,0581,972,715REDEEMABLE EQUITY

170,183207,307E
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
2. ImmunGene Announces Multi-Target R&D Collaboration With Cephalon Australia for Interferon Payload Technology
3. Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder
4. Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors
5. Cephalon to Webcast Investor Day
6. Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL
7. Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations
8. Cephalon Exercises its Option to Acquire BioAssets Development Corporation
9. Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
10. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
11. Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... ARBOR, Mich. , July 30, 2014 Advanced ... first quarter (ending June 27, 2014) financial results on Monday, ... will be released after the close of the market and ... discuss the results at 4:30 p.m. EDT on the same ... Richard Kurtz (CEO and Director), Rob Risser ...
(Date:7/30/2014)... , July 30, 2014 In conjunction with ... 2014 financial results press release, you are invited to ... live over the internet on Thursday, August 7, 2014 ... A live audio webcast of the presentation ... http://www.durect.com and clicking "Investor Relations."  If you are ...
(Date:7/30/2014)... July 30, 2014 Research and Markets has ... - Forecasts to 2019" report to their offering. ... estimated to grow at a lower CAGR in developed countries; however, ... as China , India , ... The growth of the hematology analyzers and reagents market ...
Breaking Medicine Technology:Advanced Photonix to Webcast Fiscal 2015 First Quarter Earnings 2DURECT Corporation Invites You to Join its Second Quarter 2014 Earnings Conference Call 2Hematology Analyzers & Reagents Market - Forecasts to 2019 2
(Date:7/30/2014)... Africa is being revitalized and expanded through a ... curricula, upgrading Internet access and providing cutting-edge skills ... first substantial publication by participants of the $130 ... 225 authors detailed progress being made at the ... being published today by the journal Academic ...
(Date:7/30/2014)... , Resistance to artemisinin, the main drug to ... among the Plasmodium falciparum ( P. ... is likely caused by a genetic mutation in ... combination therapyas opposed to a standard three-day coursehas ... according to findings published today in the ...
(Date:7/30/2014)... Steven Reinberg HealthDay Reporter ... the United States, at least 2,000 Americans die from extreme ... Heat waves, heat stroke or sun stroke caused nearly ... and 2010, according to the U.S. Centers for Disease Control ... loss of body heat -- accounted for 63 percent of ...
(Date:7/30/2014)... 30, 2014 (HealthDay News) -- It can happen in an ... dresser or computer monitor and gets critically injured when the ... young child should look around their homes and imagine what ... Imagining it is better than it becoming a reality," Dr. ... said in a college news release. Between 2009 and ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 SF Cable, ... at the lowest prices on the internet with guaranteed ... in two lengths and two colors. These lightning cords ... , The high quality SF Cable Lightning ... with digital signal delivering faster charging and syncing. Compatible ...
Breaking Medicine News(10 mins):Health News:Journal supplement details progress in African medical education 2Health News:Journal supplement details progress in African medical education 3Health News:Resistance to key malaria drug spreading at alarming rate in Southeast Asia 2Health News: Extreme Weather Kills 2,000 in U.S. Each Year: CDC 2Health News: Extreme Weather Kills 2,000 in U.S. Each Year: CDC 3Health News:Tip-Over Furniture Can Kill Kids 2Health News:SF Cable Delivers Certified Lightning Cable in Multiple Sizes and Colors 2
... ... 28th Hysterectomy Conference, Saturday April 23rd at the Hilton New York in Manhattan. , ... (PRWEB) March 3, 2010 -- Congresswoman ... Conference , Saturday April 23rd at the Hilton New York in Manhattan. , , ,Maloney, ...
... ... ... ... ...
... , , ... ... ... ...
... ... some dietary supplements, including two popular weight loss supplements, according to new tests ... two weight loss products and ConsumerLab.com noted concern for potential side-effects from products ... with 7-keto DHEA supplements. , ...
... ... the pounds in a fitness competition to claim coveted tech prizes. , ... Salt Lake City, UT (Vocus) March 3, 2010 -- It doesn,t ... just a few, sweet tech prizes., , , , ,"Mention ,iPad, or ,Dell Mini 5, and ...
... , ... Councils, a division of PRISM International, Inc., released its Top 25 recipient list for the ... presented during the Diversity Council Honors Award Reception at the 2010 Linkage Summit on Leading ... ...
Cached Medicine News:Health News:Congresswoman Maloney To Be Keynote Speaker: Momentum Builds for Hysterectomy Informed Consent Legislation 2Health News:Cardiac Science Sets Date for Fourth Quarter, Year-End Results Release and Conference Call 2Health News:Cardiac Science Sets Date for Fourth Quarter, Year-End Results Release and Conference Call 3Health News:Cardiac Science Sets Date for Fourth Quarter, Year-End Results Release and Conference Call 4Health News:Cardiac Science Sets Date for Fourth Quarter, Year-End Results Release and Conference Call 5Health News:Cardiac Science Sets Date for Fourth Quarter, Year-End Results Release and Conference Call 6Health News:Cardiac Science Sets Date for Fourth Quarter, Year-End Results Release and Conference Call 7Health News:Cardiac Science Sets Date for Fourth Quarter, Year-End Results Release and Conference Call 8Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 2Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 3Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 4Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 5Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 6Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 7Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 8Health News:ConsumerLab.com Finds Carcinogenic form of Chromium in Supplements, Including Those for Weight Loss 2Health News:ConsumerLab.com Finds Carcinogenic form of Chromium in Supplements, Including Those for Weight Loss 3Health News:ConsumerLab.com Finds Carcinogenic form of Chromium in Supplements, Including Those for Weight Loss 4Health News:SEO.com Slims Down in Company Fitness Contest 2Health News:The Association of Diversity Councils Announces Its 2010 Diversity Council Honors Award™ Recipients 2Health News:The Association of Diversity Councils Announces Its 2010 Diversity Council Honors Award™ Recipients 3
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Medicine Products: